Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milton EssexWAR:MTN -1.36%29 Market Cap is zł49.69 Mil as of Jul. 14, 2026. GuruFocus rates WAR:MTN with a GF Score™ of 29/100 and a GF Value™ of zł0.13 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Milton Essex ranks worse than 82.68% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Milton Essex's share price for the quarter that ended in Mar. 2026 was zł0.56. Milton Essex's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 68.54 Mil. Therefore, Milton Essex's market cap for the quarter that ended in Mar. 2026 was zł38.38 Mil.
Milton Essex's quarterly market cap
declined
from Sep. 2025 (zł14.51 Mil) to Dec. 2025 (zł11.79 Mil) but then
increased
from Dec. 2025 (zł11.79 Mil) to Mar. 2026 (zł38.38 Mil).
Milton Essex's annual market cap
declined
from Dec. 2023 (zł7.84 Mil) to Dec. 2024 (zł5.56 Mil) but then
increased
from Dec. 2024 (zł5.56 Mil) to Dec. 2025 (zł11.79 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Milton Essex's Enterprise Value for Today is zł51.20 Mil.
Milton Essex (WAR:MTN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Milton Essex Market Cap Related Terms
Milton Essex Market Cap Historical Data
* Premium members only.
The historical data trend for Milton Essex's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Milton Essex's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milton Essex Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milton Essex's Market Cap distribution charts can be found below:
* The bar in red indicates where Milton Essex's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Milton Essex's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milton Essex (WAR:MTN) has a Market Cap of zł49.69 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Milton Essex and its competitors. According to the industry distribution chart, Milton Essex ranks #716 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 82.7%.
Is Milton Essex's Market Cap too high?
Milton Essex's current Market Cap is zł49.69 Mil. Based on the distribution chart, Milton Essex ranks #716 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Milton Essex has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Milton Essex's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Milton Essex ranks #716 out of 866 companies for Market Cap. This places Milton Essex in the lower half of its industry. The industry median Market Cap is 116.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.94, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Milton Essex and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milton Essex's current Market Cap is zł49.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milton Essex stock overvalued right now?
Based on GuruFocus' analysis, Milton Essex (WAR:MTN) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.13, compared to a current price of zł0.73 — trading 457.7% above its estimated fair value. The current Market Cap is zł49.69 Mil. Milton Essex's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Milton Essex (WAR:MTN), the current Market Cap is zł49.69 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Milton Essex (WAR:MTN) Overvalued in 2026?
Based on GuruFocus' analysis, Milton Essex stock appears to be overvalued.
The current stock price of zł0.73 is trading 457.7% above its estimated GF Value™ of zł0.13.
GuruFocus considers Milton Essex to be Significantly Overvalued.
Key valuation signals for WAR:MTN:
Market Cap: zł49.69 Mil
GF Value™: zł0.13 vs. price of zł0.73 (457.7% above fair value)
No single metric tells the full story. See the WAR:MTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Milton Essex SA provides contact-free hybrid scanners for allergology and oncological dermatology. The products of the company include Ski Sense, FaceCov and InfraSkin.
29GF Score
Get the complete analysis for WAR:MTN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MTN has been successfully added to your 
